Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity.

Abstract:

:Wild-type human p53 protein is able to self-associate and consists predominantly of homotetramers in solution. In earlier work we identified the protein sequence motifs involved in p53 quaternary structure and showed that while monomeric p53 protein retains tumour suppressor function, monomeric tumour mutant p53 lacks dominant transforming activity. In this report we use point mutated and truncated cDNA genes encoding self-association defective human p53 proteins to investigate the relationship between p53 protein quaternary structure and the associated activities of transcription transactivation and target specific DNA binding. We show that p53 binds to a target oligonucleotide as a protein homodimer and that p53 dimerisation is required for detectable DNA binding. We found no evidence for p53 tetramer: DNA complexes and we suggest that the quaternary structure status of p53 may regulate a DNA binding associated activity. Monomeric p53 proteins failed to bind DNA in these assays but exhibited increased transactivating activity. Thus, both transcription transactivation and tumour suppressor functions act independently of p53 protein self-association and DNA binding. We propose that our results validate the p53 dimerisation motif as a target for rational anticancer drug design. We predict that compounds able to block p53 dimer assembly would inhibit the dominant transforming activities of mutant p53 in tumours retaining expression of a mutant allele, while leaving intact the wild-type p53 associated activities of transcription transactivation and transformation suppression in unaffected tissue.

journal_name

Oncogene

journal_title

Oncogene

authors

Tarunina M,Jenkins JR

subject

Has Abstract

pub_date

1993-11-01 00:00:00

pages

3165-73

issue

11

eissn

0950-9232

issn

1476-5594

journal_volume

8

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.

    abstract::CCAAT/enhancer-binding protein-δ (C/EBP-δ), a transcription factor, is elevated in carcinoma compared with that in normal tissue. This study reports a novel function of C/EBP-δ in lymphangiogenesis and tumor metastasis. Genetic deletion of C/EBP-δ in mice resulted in a significant reduction of lymphangiogenesis and pu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.187

    authors: Min Y,Ghose S,Boelte K,Li J,Yang L,Lin PC

    更新日期:2011-12-08 00:00:00

  • An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer.

    abstract::Poor-prognosis oestrogen receptor-positive breast cancer is characterised by the presence of high-level focal amplifications. We utilised a focused small interfering RNA screen in 14 breast cancer cell lines to define genes that were pathogenic in three genomic regions focally amplified in oestrogen receptor-positive ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.202

    authors: Garcia-Murillas I,Sharpe R,Pearson A,Campbell J,Natrajan R,Ashworth A,Turner NC

    更新日期:2014-05-08 00:00:00

  • MicroRNA dysregulation in gastric cancer: a new player enters the game.

    abstract::Gastric carcinogenesis is a multistep process involving genetic and epigenetic alteration of protein-coding proto-oncogenes and tumor-suppressor genes. Recent discoveries have shed new light on the involvement of a class of noncoding RNA known as microRNA (miRNA) in gastric cancer. A substantial number of miRNAs show ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.352

    authors: Wu WK,Lee CW,Cho CH,Fan D,Wu K,Yu J,Sung JJ

    更新日期:2010-10-28 00:00:00

  • Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

    abstract::Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; howev...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.318

    authors: Sveen A,Kilpinen S,Ruusulehto A,Lothe RA,Skotheim RI

    更新日期:2016-05-12 00:00:00

  • GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.

    abstract::Intraductal papillary mucinous neoplasm (IPMN), the most common pancreatic cystic neoplasm, is known to progress to invasive ductal adenocarcinoma. IPMNs commonly harbor activating somatic mutations in GNAS and KRAS, primarily GNAS(R201H) and KRAS(G12D). GNAS encodes the stimulatory G-protein α subunit (Gsα) that medi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.294

    authors: Taki K,Ohmuraya M,Tanji E,Komatsu H,Hashimoto D,Semba K,Araki K,Kawaguchi Y,Baba H,Furukawa T

    更新日期:2016-05-05 00:00:00

  • Characterization of transcription factor E2F complexes during muscle and neuronal differentiation.

    abstract::The activities of E2F transcription factors are inhibited by interactions with members of the retinoblastoma (RB) tumor suppressor family, p105RB, p107 and p130. In cycling cells p107 and p130 also interact with heterodimers comprised of Cdk2 and either A or E cyclins. We characterized E2F complexes present in C2C12 a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Corbeil HB,Whyte P,Branton PE

    更新日期:1995-09-07 00:00:00

  • DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.

    abstract::Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.399

    authors: Fan H,Cui Z,Zhang H,Mani SK,Diab A,Lefrancois L,Fares N,Merle P,Andrisani O

    更新日期:2017-04-27 00:00:00

  • The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein.

    abstract::The Epstein-Barr virus latency-associated membrane protein LMP2A has been shown to activate the survival kinase Akt in epithelial and B cells in a phosphoinositide 3-kinase-dependent fashion. In this study, we demonstrate that the signalling scaffold Shb associates through SH2 and PTB domain interactions with phosphor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210298

    authors: Matskova LV,Helmstetter C,Ingham RJ,Gish G,Lindholm CK,Ernberg I,Pawson T,Winberg G

    更新日期:2007-07-26 00:00:00

  • Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.

    abstract::Tuberin is the protein product of the tuberous sclerosis-2 (TSC2) gene, which is associated with tuberous sclerosis (TSC), a human genetic syndrome characterized by the development of tumors in a variety of tissues. We have previously shown that tuberin is a widely expressed 180 kDa protein which exhibits specific GTP...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wienecke R,Maize JC Jr,Shoarinejad F,Vass WC,Reed J,Bonifacino JS,Resau JH,de Gunzburg J,Yeung RS,DeClue JE

    更新日期:1996-09-05 00:00:00

  • Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.

    abstract::p53 is known to play a role in iron homeostasis and is required for FDXR-mediated iron metabolism via iron regulatory protein 2 (IRP2). Interestingly, p53 is frequently mutated in tumors wherein iron is often accumulated, suggesting that mutant p53 may exert its gain of function by altering iron metabolism. In this st...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0876-5

    authors: Zhang Y,Feng X,Zhang J,Chen M,Huang E,Chen X

    更新日期:2019-08-01 00:00:00

  • Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis.

    abstract::We have previously shown that tumor necrosis factor (TNF)α produced from primary tumor-induced expression of two endogenous Toll-like receptor 4 (TLR4) ligands, S100A8 and serum amyloid A3 (SAA3), in pre-metastatic lungs. However, mechanistic details of the signaling network and relevance to pulmonary physiology are p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.53

    authors: Tomita T,Sakurai Y,Ishibashi S,Maru Y

    更新日期:2011-08-04 00:00:00

  • Methyltransferase inhibition induces p53-dependent apoptosis and a novel form of cell death.

    abstract::We have analysed the importance of proper substrate methylation by S-adenosylmethionine-dependent methyltransferases for cell survival and cell cycle progression. We show that treatment of cells with the methyltransferase inhibitor adenosine dialdehyde (AdOx) causes cell cycle arrest and death in different cell types....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208855

    authors: Schwerk C,Schulze-Osthoff K

    更新日期:2005-10-27 00:00:00

  • AP-1 complex is effector of Hox-induced cellular proliferation and transformation.

    abstract::Hox gene products, initially characterized as master regulators of embryonic patterning, are also required for proper functioning of adult tissues. There is also a growing body of evidence that links Hox proteins to regulation of cellular proliferation/transformation. However, the underlying molecular mechanisms of Ho...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203897

    authors: Krosl J,Sauvageau G

    更新日期:2000-10-26 00:00:00

  • Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.

    abstract::Tamoxifen (Tam), besides its action as an anti-estrogen, also inhibits cell proliferation of estrogen receptor (ER)-negative cancer cells by an unknown mechanism. In this study, we used ER-negative lung cancer cells to clarify such ER-independent inhibitory effect of Tam. We found that Tam induced G1 growth arrest in ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202755

    authors: Lee TH,Chuang LY,Hung WC

    更新日期:1999-07-22 00:00:00

  • Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.

    abstract::Two thirds of breast cancers express estrogen receptors (ER). ER alpha (ERα) mediates breast cancer cell proliferation, and expression of ERα is the standard choice to indicate adjuvant endocrine therapy. ERbeta (ERβ) inhibits growth in vitro; its effects in vivo have been incompletely investigated and its role in bre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.261

    authors: Cotrim CZ,Fabris V,Doria ML,Lindberg K,Gustafsson JÅ,Amado F,Lanari C,Helguero LA

    更新日期:2013-05-09 00:00:00

  • Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.

    abstract::To understand the function of the individual oncogenes of HPV16 in modulating the cellular response to apoptogenic signals, we used human keratinocytes immortalized with either E6, E7 or E6/E7 oncoproteins as model system. Applying CD95 antibodies or recombinant CD95 ligand, only the E7-immortalized cells underwent ex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204979

    authors: Aguilar-Lemarroy A,Gariglio P,Whitaker NJ,Eichhorst ST,zur Hausen H,Krammer PH,Rösl F

    更新日期:2002-01-10 00:00:00

  • Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.

    abstract::Interleukin-8 (IL-8), a chemokine implicated in the metastasis and angiogenesis of a variety of cancers, has been reported to be overexpressed in prostate cancer. In this study, we ascribe a new role for IL-8 in prostate cancer progression using LNCaP cells. We demonstrate that IL-8 activates the androgen receptor and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207344

    authors: Lee LF,Louie MC,Desai SJ,Yang J,Chen HW,Evans CP,Kung HJ

    更新日期:2004-03-18 00:00:00

  • The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein.

    abstract::The products of the proto-oncogenes c-jun and c-fos are known to form a complex in vivo. Complex formation appears to stabilize protein-DNA interactions and is thought to play an important functional role in transcriptional regulation. Here we show that the viral Jun oncoprotein, which differs structurally from cellul...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bos TJ,Rauscher FJ 3rd,Curran T,Vogt PK

    更新日期:1989-02-01 00:00:00

  • Cloning of the human Gfi-1 gene and its mapping to chromosome region 1p22.

    abstract::Recently the rat and mouse Growth Factor Independence (Gfi-1) genes have been cloned (Gilks et al., 1993; Zoring et al; 1996). This gene allows cells in culture to overcome the depletion of growth factors in the culture medium and maintain their proliferative potential. As part of a cloning strategy to isolated genes ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200910

    authors: Roberts T,Cowell JK

    更新日期:1997-02-27 00:00:00

  • RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells.

    abstract::The S-phase kinase-associated protein-2 (SKP2) plays a key role in ubiquitin-mediated proteolysis, which results in the progression of cells from a quiescence to proliferative state. SKP2 is overexpressed in a variety of tumors. In this study, we used small interfering RNAs (siRNAs) to inhibit the SKP2 expression in l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208459

    authors: Jiang F,Caraway NP,Li R,Katz RL

    更新日期:2005-05-12 00:00:00

  • Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.

    abstract::The cysteine protease cathepsin B (CTSB) is frequently overexpressed in human breast cancer and correlated with a poor prognosis. Genetic deficiency or pharmacological inhibition of CTSB attenuates tumor growth, invasion and metastasis in mouse models of human cancers. CTSB is expressed in both cancer cells and cells ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.395

    authors: Bengsch F,Buck A,Günther SC,Seiz JR,Tacke M,Pfeifer D,von Elverfeldt D,Sevenich L,Hillebrand LE,Kern U,Sameni M,Peters C,Sloane BF,Reinheckel T

    更新日期:2014-09-04 00:00:00

  • Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.

    abstract::Chromosomal aberrations are a hallmark of human cancers, with complex cytogenetic rearrangements leading to genetic changes permissive for cancer initiation and progression. Protection of Telomere 1 (POT1) is an essential component of the shelterin complex and functions to maintain chromosome stability by repressing t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.405

    authors: Gu P,Wang Y,Bisht KK,Wu L,Kukova L,Smith EM,Xiao Y,Bailey SM,Lei M,Nandakumar J,Chang S

    更新日期:2017-04-06 00:00:00

  • HUS1 regulates in vivo responses to genotoxic chemotherapies.

    abstract::Cells are under constant attack from genotoxins and rely on a multifaceted DNA damage response (DDR) network to maintain genomic integrity. Central to the DDR are the ATM and ATR kinases, which respond primarily to double-strand DNA breaks (DSBs) and replication stress, respectively. Optimal ATR signaling requires the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.118

    authors: Balmus G,Lim PX,Oswald A,Hume KR,Cassano A,Pierre J,Hill A,Huang W,August A,Stokol T,Southard T,Weiss RS

    更新日期:2016-02-04 00:00:00

  • The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.

    abstract::Promoter hypermethylation is an important means for the transcriptional repression of a number of cancer-associated genes. However, the underlying mechanism of this aberration in cancer remains unclear. Here, we examined 5' CpG island methylation status and expression of the p14(ARF), p16(INK4a) and RASSF1A tumor supp...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205581

    authors: Sato M,Horio Y,Sekido Y,Minna JD,Shimokata K,Hasegawa Y

    更新日期:2002-07-18 00:00:00

  • Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

    abstract::Next-generation sequencing (NGS) technology has demonstrated that the cancer genomes are peppered with mutations. Although most somatic tumour mutations are unlikely to have any role in the cancer process per se, the spectra of DNA sequence changes in tumour mutation catalogues have the potential to identify the mutag...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.192

    authors: Hollstein M,Alexandrov LB,Wild CP,Ardin M,Zavadil J

    更新日期:2017-01-12 00:00:00

  • Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells.

    abstract::Augmented reactive oxygen species levels consequential to functional alteration of key mitochondrial attributes contribute to carcinogenesis, either directly via oxidative DNA damage infliction or indirectly via activation of oncogenic signaling cascades. We previously reported activation of a key oncogenic signaling ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.346

    authors: Lone MU,Baghel KS,Kanchan RK,Shrivastava R,Malik SA,Tewari BN,Tripathi C,Negi MP,Garg VK,Sharma M,Bhatt ML,Bhadauria S

    更新日期:2017-03-30 00:00:00

  • Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.

    abstract::The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matrix remodeling factors, and might be implicated in disease progression of breast cancer. In the present study, the prognostic value of Ets-1 expression was assessed by quantitative real-time fluorescence RT-PCR in 123 sp...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206040

    authors: Span PN,Manders P,Heuvel JJ,Thomas CM,Bosch RR,Beex LV,Sweep CG

    更新日期:2002-12-05 00:00:00

  • Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.

    abstract::The KLF6 gene encodes the Krüppel-like factor 6, a transcription factor that has been individualized as a tumor-suppressor gene involved in the regulation of cell proliferation and differentiation. Recently, high frequency (42%) of KLF6 mutations have been reported in colorectal cancers (CRC) as in prostate cancers, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208867

    authors: Lièvre A,Landi B,Côté JF,Veyrie N,Zucman-Rossi J,Berger A,Laurent-Puig P

    更新日期:2005-11-03 00:00:00

  • Genetics of melanoma predisposition.

    abstract::Predisposition to melanoma is genetically heterogeneous. Two high penetrance susceptibility genes, CDKN2A and CDK4, have so far been identified and mapping is ongoing to localize and identify others. With the advent of a catalogue of millions of potential DNA polymorphisms, attention is now also being focused on ident...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1206445

    authors: Hayward NK

    更新日期:2003-05-19 00:00:00

  • Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells.

    abstract::Several lines of evidence suggest that gastrin and the CCK-2 receptor (CCK2R) could contribute to pancreatic carcinogenesis by modulating processes such as proliferation, cell adhesion or migration. In the current study, we used a 'cancer gene array' and identified beta1-integrin subunit as a new gastrin-regulated gen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209484

    authors: Cayrol C,Clerc P,Bertrand C,Gigoux V,Portolan G,Fourmy D,Dufresne M,Seva C

    更新日期:2006-07-27 00:00:00